<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title-group>
<journal-title>Brain</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29961870</article-id>
<article-id pub-id-type="pmc">6061692</article-id>
<article-id pub-id-type="doi">10.1093/brain/awy171</article-id>
<article-id pub-id-type="publisher-id">awy171</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
<subj-group subj-group-type="category-oup-series">
<subject>Editor's Choice</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>De novo</italic> variants in <italic>GABRA2</italic> and <italic>GABRA5</italic> alter receptor function and contribute to early-onset epilepsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Butler</surname>
<given-names>Kameryn M</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF1">1</xref>
<xref ref-type="aff" rid="awy171-AFF2">2</xref>
<xref ref-type="author-notes" rid="awy171-FN1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moody</surname>
<given-names>Olivia A</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF3">3</xref>
<xref ref-type="aff" rid="awy171-AFF4">4</xref>
<xref ref-type="author-notes" rid="awy171-FN1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schuler</surname>
<given-names>Elisabeth</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coryell</surname>
<given-names>Jason</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alexander</surname>
<given-names>John J</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF1">1</xref>
<xref ref-type="aff" rid="awy171-AFF7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jenkins</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Escayg</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="awy171-AFF1">1</xref>
<xref ref-type="corresp" rid="awy171-COR1"></xref>
<!--<email>aescayg@emory.edu</email>-->
</contrib>
</contrib-group>
<aff id="awy171-AFF1"><label>1</label>Department of Human Genetics, Emory University, Atlanta, Georgia, 30322, USA</aff>
<aff id="awy171-AFF2"><label>2</label>Genetics and Molecular Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, Georgia, 30322, USA</aff>
<aff id="awy171-AFF3"><label>3</label>Departments of Anesthesiology and Pharmacology, Emory University, Atlanta, Georgia, 30322, USA</aff>
<aff id="awy171-AFF4"><label>4</label>Neuroscience Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, Georgia, 30322, USA</aff>
<aff id="awy171-AFF5"><label>5</label>Department for Pediatric Metabolic Medicine and Neurology, University Children’s Hospital, Heidelberg, 69120, Germany</aff>
<aff id="awy171-AFF6"><label>6</label>Departments of Pediatrics and Neurology, School of Medicine, Oregon Health &amp; Sciences University, Portland, Oregon, 97239, USA</aff>
<aff id="awy171-AFF7"><label>7</label>EGL Genetics, Tucker, Georgia, 30084, USA</aff>
<author-notes>
<corresp id="awy171-COR1">Correspondence to: Andrew Escayg Department of Human Genetics Emory University 615 Michael Street Room 361 Atlanta, Georgia 30322, USA E-mail: <email>aescayg@emory.edu</email></corresp>
<fn id="awy171-FN1">
<p>Kameryn M. Butler and Olivia A. Moody authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-06-28" pub-type="epub">
<day>28</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>141</volume>
<issue>8</issue>
<fpage>2392</fpage>
<lpage>2405</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>2</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) (2018). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">https://academic.oup.com/journals/pages/about_us/legal/notices</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="awy171.pdf"></self-uri>
<abstract abstract-type="teaser">
<p>GABA<sub>A</sub> receptors are important regulators of neuronal inhibition. Butler <italic>et al</italic>. identify <italic>de novo</italic> variants in <italic>GABRA2</italic> and <italic>GABRA5</italic>, encoding α2 and α5 receptor subunits, respectively, as causes of paediatric epilepsy and developmental delay.</p>
</abstract>
<abstract>
<title>Abstract</title>
<p>GABA<sub>A</sub> receptors are ligand-gated anion channels that are important regulators of neuronal inhibition. Mutations in several genes encoding receptor subunits have been identified in patients with various types of epilepsy, ranging from mild febrile seizures to severe epileptic encephalopathy. Using whole-genome sequencing, we identified a novel <italic>de novo</italic> missense variant in <italic>GABRA5</italic> (c.880G &gt; C, p.V294L) in a patient with severe early-onset epilepsy and developmental delay. Targeted resequencing of 279 additional epilepsy patients identified 19 rare variants from nine GABA<sub>A</sub> receptor genes, including a novel <italic>de novo</italic> missense variant in <italic>GABRA2</italic> (c.875C &gt; A, p.T292K) and a recurrent missense variant in <italic>GABRB3</italic> (c.902C &gt; T, p.P301L). Patients with the <italic>GABRA2</italic> and <italic>GABRB3</italic> variants also presented with severe epilepsy and developmental delay. We evaluated the effects of the <italic>GABRA5</italic>, <italic>GABRA2</italic> and <italic>GABRB3</italic> missense variants on receptor function using whole-cell patch-clamp recordings from human embryonic kidney 293T cells expressing appropriate α, β and γ subunits. The <italic>GABRA5</italic> p.V294L variant produced receptors that were 10-times more sensitive to GABA but had reduced maximal GABA-evoked current due to increased receptor desensitization. The <italic>GABRA2</italic> p.T292K variant reduced channel expression and produced mutant channels that were tonically open, even in the absence of GABA. Receptors containing the <italic>GABRB3</italic> p.P301L variant were less sensitive to GABA and produced less GABA-evoked current. These results provide the first functional evidence that <italic>de novo</italic> variants in the <italic>GABRA5</italic> and <italic>GABRA2</italic> genes contribute to early-onset epilepsy and developmental delay, and demonstrate that epilepsy can result from reduced neuronal inhibition via a wide range of alterations in GABA<sub>A</sub> receptor function.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>GABRA2</kwd>
<kwd>GABRA5</kwd>
<kwd>GABRB3</kwd>
<kwd>epileptic encephalopathy</kwd>
<kwd>GABA<sub>A</sub> receptor</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01 NS089719</award-id>
<award-id>5T32GM008490</award-id>
<award-id>T32NS007480</award-id>
<award-id>T32GM008602</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Children's Healthcare of Atlanta</named-content>
<named-content content-type="funder-identifier">10.13039/100012423</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Emory University Research Council</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>